Nova Southeastern University
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Nova Southeastern University sits in the top decile of US sponsors by registered trial count (#303 of 15,742 sponsors by registered trial count).
Nova Southeastern University: 71 sponsored US clinical trials, 15 recruiting.
Nova Southeastern University sponsors 71 registered US clinical trials on ClinicalTrials.gov, 15 of them currently recruiting, and 50 completed. 2 of these trials are in Phase 3-4 (later-stage) and 11 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Gulf War Illness, with 2 trials.
Top-decile sponsor footprint
Nova Southeastern University ranks in the top decile of sponsors by registered trial count (#303 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
50 of 52 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (96.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
71 total, page 2 of 2
Scapular Stabilization During Manual Horizontal Adduction Stretches and Its Effect on Increasing Posterior Shoulder Flexibility
NCT02085200
The Most Effective Intervention for Reducing Posterior Shoulder Tightness Acutely in the Post-operative Population
NCT01810211
A Self-Assessment Intervention for Young Adult Polydrug Users at Risk for HIV
NCT01362634
Project Power: An HIV Risk Reduction Intervention for Black Men Who Have Sex With Men and Women (BMSM/W)
NCT01376895
The Effectiveness of Diagnosis and Treatment of Thoracic Outlet Syndrome
NCT01342068
Nutritional Intervention in Children With Autism Using Whey Protein (Immunocal): Impact on Core Areas of Behavior
NCT01366859
Association of Biomechanical Changes and Weight Gain Throughout Pregnancy
NCT01315860
Motiv82Change: an HIV Prevention Study for Young Latino Men
NCT00877695
An Automated, Tailored Information Application for Medication Health Literacy
NCT01304186
The Effect of Somatic Dysfunction of the Pelvis, Sacrum and Lower Lumbar Spine on Weight Bearing
NCT01097109
Risk Reduction for Urban Substance Using Men Who Have Sex With Men (MSM)
NCT01327898
Study of Physical Health for Women With Posttraumatic Stress or Depression
NCT01208844
Promoting Self-Change From Alcohol Problems: Mechanisms of Change in a Community-Based Intervention
NCT00732095
The Human Immunodeficiency Virus and Osteopathic Manipulation Evaluation Study
NCT00703248
Determination of Forces Used in Palpatory Diagnosis
NCT00781144
Case Management Alternatives for African American Women at High Risk for HIV
NCT00780260
A Media Based Motivational Intervention to Prevent Alcohol Exposed Pregnancies (AEPs)
NCT00219336
Effects of OA Decompression on the Autonomic Nervous System
NCT00403936
Eye on Diabetes: A Multidisciplinary Patient Education Intervention
NCT00417924
Effect of Osteopathic Cranial Manipulative Medicine on Visual Function
NCT02728713
Effect of Cranial Osteopathy on Visual Function
NCT00510562
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 6 |
| Phase 2 | 5 |
| Phase 3 | 2 |
Therapeutic Areas
What is open in the Nova Southeastern University pipeline
15 recruiting of 71 indexed (21% open); 50 completed (70%).
Phase mix: 2 late (III/IV) vs 11 early (I/II) (early-phase heavy).
Top condition: Gulf War Illness (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Nova Southeastern University: open-pipeline peers nationwide
Peers matched on 71 registered trials and 21% open enrollment, not the therapeutic-area sidebar.
Nova Southeastern University sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 71 trials (± recruiting share)
- CSL Behring · 71 trials · 17% recruiting
- EMD Serono · 71 trials · 0% recruiting
- H. Lundbeck A/S · 72 trials · 7% recruiting
- Smith & Nephew · 72 trials · 4% recruiting
Sponsors near 21% open enrollment (± trial volume)
- Ohio State University · 21% recruiting · 552 trials
- University of Louisville · 21% recruiting · 217 trials
- InSightec · 21% recruiting · 38 trials
- Medical College of Wisconsin · 21% recruiting · 447 trials
Related
What to do with this Nova Southeastern University page
71 registered trials is a research-attention snapshot, not an endorsement of Nova Southeastern University or any single study.
- 15 of Nova Southeastern University's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Gulf War Illness is the condition Nova Southeastern University studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Gulf War Illness trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Nova Southeastern University pipeline card: 71 registered trials from official public datasets.Report a data error.